Generate Biomedicines, Inc. — All Filings
43 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | 3 | 0000950130-26-000106 | Mar 12, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-096799 | Mar 6, 2026 | Mar 4, 2026 |
| 4 | 4 | 0001193125-26-085952 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-085939 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-085928 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-085911 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-085910 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-085903 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-085898 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-085888 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-085886 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-085883 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-085881 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-085872 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-085871 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-085861 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-085855 | Mar 2, 2026 | Feb 26, 2026 |
| 8-K | 8-K | 0001193125-26-085780 | Mar 2, 2026 | Feb 26, 2026 |
| S-8 | S-8 | 0001193125-26-083253 | Feb 27, 2026 | — |
| 424B4 | 424B4 | 0001193125-26-083190 | Feb 27, 2026 | — |
| EFFECT | — | 9999999995-26-000677 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078748 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078738 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078483 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078427 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078419 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078415 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078413 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078412 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078405 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078404 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078397 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078395 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078385 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078381 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078355 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-078349 | Feb 26, 2026 | — |
| CERT | — | 0001354457-26-000222 | Feb 26, 2026 | — |
| 8-A12B | 8-A12B | 0001193125-26-067219 | Feb 24, 2026 | — |
| S-1/A | S-1/A | 0001193125-26-062362 | Feb 23, 2026 | — |
| S-1/A | S-1/A | 0001193125-26-051761 | Feb 13, 2026 | — |
| S-1 | S-1 | 0001193125-26-037799 | Feb 4, 2026 | — |
| DRS | — | 0001193125-25-330964 | Dec 23, 2025 | — |